APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,303,033 | +0.4% | 191,983 | +140.6% | 0.02% | -26.9% |
| Q2 2023 | $7,270,600 | -13.7% | 79,809 | -37.5% | 0.03% | -79.4% |
| Q1 2023 | $8,428,237 | +494.9% | 127,778 | +366.3% | 0.13% | +384.6% |
| Q4 2022 | $1,416,854 | +29.6% | 27,400 | +71.2% | 0.03% | +23.8% |
| Q3 2022 | $1,093,000 | +69.5% | 16,000 | +26.1% | 0.02% | +23.5% |
| Q1 2022 | $645,000 | -88.1% | 12,687 | -89.0% | 0.02% | -89.9% |
| Q4 2021 | $5,443,000 | +742.6% | 115,133 | +377.7% | 0.17% | +19.0% |
| Q1 2020 | $646,000 | – | 24,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |